Skip to main content
Top
Published in: Clinical and Translational Oncology 5/2016

01-05-2016 | Research Article

Trends in lung cancer incidence by histologic subtype in the south of Spain, 1985–2012: a population-based study

Authors: I. Linares, E. Molina-Portillo, J. Expósito, J. A. Baeyens, C. Suárez, M. J. Sánchez

Published in: Clinical and Translational Oncology | Issue 5/2016

Login to get access

Abstract

Purpose

To analyze and interpret age- and sex-specific incidence trends of lung cancer in Granada over the period 1985–2012 and to further analyze these trends by histologic subtype.

Methods

Incidence data were obtained from the population-based cancer registry located in Granada (Southern Spain). All cases with newly diagnosed primary lung cancer over the period 1985–2012 (n = 8658) and defined by International Classification of Diseases 10th Revision (codes C33–C34) were included. Joinpoint regression analysis of age-standardized incidence rates was used to estimate the annual percent change (APC) and 95 % confidence intervals. Results are presented overall and by sex, age groups (0–34, 35–54, 55–64, 65–74, ≥75 years) and histologic subtypes.

Results

Temporal trends of incidence rates by sex, over the period 1985–2012, showed a distinct pattern. A significant change point of the trend was observed in males in 1994 (APC: +2.5 %; 95 % CI 0.7–4.4 from 1985 to 1994 and −1.4 %; 95 % CI −2.0 to −0.7 from 1994 onward). This general change was mainly caused by the age group 65–74 years and by the higher incidence of squamous cell carcinoma histologic subtype. In females, lung cancer incidence increased over the entire study period by +4.2 % per year (95 % CI 3.1–5.4); this trend was mainly caused by the age group 55–64 years (APC = +7 %) and by adenocarcinoma incidence between women (APC = +6.8 %).

Conclusion

Male lung cancer incidence rates have decreased in Granada, while female rates have increased overall especially in younger women. These trends may reflect the increased consumption of cigarettes in women, especially during younger ages. Lung cancer prevention through tobacco control policies are therefore of utmost importance.
Literature
1.
go back to reference Brambilla E, Travis WD. Lung cancer. In: Stewart BW, Wild CP, editors. World cancer report. Lyon: World Health Organization; 2014. Brambilla E, Travis WD. Lung cancer. In: Stewart BW, Wild CP, editors. World cancer report. Lyon: World Health Organization; 2014.
2.
go back to reference Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127(12):2893–917.CrossRefPubMed Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127(12):2893–917.CrossRefPubMed
3.
go back to reference Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer. 2013;49:1374–403.CrossRefPubMed Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer. 2013;49:1374–403.CrossRefPubMed
4.
go back to reference Steliarova-Foucher E, O’callaghan M, Ferlay J, Masuyer E, Forman D, Comber H, et al. European cancer Observatory: cancer incidence, mortality, prevalence and survival in Europe. Version 1.0 (September 2012). European Network of Cancer Registries. International Agency for Research on Cancer; 2012. http://cco.iarc.fr. Steliarova-Foucher E, O’callaghan M, Ferlay J, Masuyer E, Forman D, Comber H, et al. European cancer Observatory: cancer incidence, mortality, prevalence and survival in Europe. Version 1.0 (September 2012). European Network of Cancer Registries. International Agency for Research on Cancer; 2012. http://​cco.​iarc.​fr.
5.
go back to reference Sánchez MJ, Payer T, De Angelis R, Larrañaga N, Capocaccia R, Martinez C. Cancer incidence and mortality in Spain: estimates and projections for the period 1981–2012. Ann Oncol: ESMO. 2010;21 Suppl 3(Supplement 3):iii30–6. Sánchez MJ, Payer T, De Angelis R, Larrañaga N, Capocaccia R, Martinez C. Cancer incidence and mortality in Spain: estimates and projections for the period 1981–2012. Ann Oncol: ESMO. 2010;21 Suppl 3(Supplement 3):iii30–6.
6.
go back to reference Pesch B, Kendzia B, Gustavsson P, Jöckel KH, Johnen G, Pohlabeln H, et al. Cigarette smoking and lung cancer–relative risk estimates for the major histological types from a pooled analysis of case-control studies. Int J Cancer. 2012;131(5):1210–9.CrossRefPubMedPubMedCentral Pesch B, Kendzia B, Gustavsson P, Jöckel KH, Johnen G, Pohlabeln H, et al. Cigarette smoking and lung cancer–relative risk estimates for the major histological types from a pooled analysis of case-control studies. Int J Cancer. 2012;131(5):1210–9.CrossRefPubMedPubMedCentral
8.
go back to reference Remon J, Molina-Montes E, Majem M, Lianes P, Isla D, Garrido P, et al. Lung cancer in women: an overview with special focus on Spanish women. Clin Transl Oncol. 2014;16:517–28.PubMed Remon J, Molina-Montes E, Majem M, Lianes P, Isla D, Garrido P, et al. Lung cancer in women: an overview with special focus on Spanish women. Clin Transl Oncol. 2014;16:517–28.PubMed
9.
go back to reference Fernandez E, Schiaffino A, Borràs JM, Shafey O, Villalbí JR, La Vecchia C. Prevalence of cigarette smoking by birth cohort among males and females in Spain 1010–1990. Eur J Cancer Prev. 2003;12:57–62.CrossRefPubMed Fernandez E, Schiaffino A, Borràs JM, Shafey O, Villalbí JR, La Vecchia C. Prevalence of cigarette smoking by birth cohort among males and females in Spain 1010–1990. Eur J Cancer Prev. 2003;12:57–62.CrossRefPubMed
10.
go back to reference Radzikowska E, Glaz P, Roszkowski K. Lung cancer in women: age, smoking, histology, performance status, stage, initial treatment and survival. Population based study of 20561 cases. Ann Oncol. 2002;13(13):1087–93.CrossRefPubMed Radzikowska E, Glaz P, Roszkowski K. Lung cancer in women: age, smoking, histology, performance status, stage, initial treatment and survival. Population based study of 20561 cases. Ann Oncol. 2002;13(13):1087–93.CrossRefPubMed
11.
go back to reference Thun MJ, Lally CA, Flannery JT, Calle EE, Flanders WD, Heath CW Jr. Cigarette smoking and changes in the histopathology of lung cancer. J Natl Cancer Inst. 1997;89:1580–6.CrossRefPubMed Thun MJ, Lally CA, Flannery JT, Calle EE, Flanders WD, Heath CW Jr. Cigarette smoking and changes in the histopathology of lung cancer. J Natl Cancer Inst. 1997;89:1580–6.CrossRefPubMed
12.
go back to reference Salmerón D, Chirlaque MD, Izarzugaza MI, Sánchez MJ, Marcos-Gragera R, Ardanaz E, et al. Lung cancer prognosis in Spain: the role of histology, age and sex. Respir Med. 2012;106:1301–8.CrossRefPubMed Salmerón D, Chirlaque MD, Izarzugaza MI, Sánchez MJ, Marcos-Gragera R, Ardanaz E, et al. Lung cancer prognosis in Spain: the role of histology, age and sex. Respir Med. 2012;106:1301–8.CrossRefPubMed
13.
go back to reference Devesa SS, Bray F, Vizcaino AP, Parkin DM. International lung cancer trends by histologic type: male: female differences diminishing and adenocarcinoma rates rising. Int J Cancer. 2005;117(2):294–9.CrossRefPubMed Devesa SS, Bray F, Vizcaino AP, Parkin DM. International lung cancer trends by histologic type: male: female differences diminishing and adenocarcinoma rates rising. Int J Cancer. 2005;117(2):294–9.CrossRefPubMed
14.
15.
go back to reference Keohavong P, De Michele MA, Melacrinos AC, Landreneau RJ, Weyant RJ, Siegfried JM. Detection of K-ras mutations in lung carcinomas: relationship to prognosis. Clin Cancer Res. 1996;2:411–8.PubMed Keohavong P, De Michele MA, Melacrinos AC, Landreneau RJ, Weyant RJ, Siegfried JM. Detection of K-ras mutations in lung carcinomas: relationship to prognosis. Clin Cancer Res. 1996;2:411–8.PubMed
17.
go back to reference Fritz A, Percy C, Jack A, Shanmugaratnam K, Sobin L, Parkin DM, et al., editors. International classification of diseases for oncology. 3rd ed. Geneva: World Health Organization; 2000. Fritz A, Percy C, Jack A, Shanmugaratnam K, Sobin L, Parkin DM, et al., editors. International classification of diseases for oncology. 3rd ed. Geneva: World Health Organization; 2000.
18.
go back to reference Percy C, Van Holten V, Muir C, editors. International classification of diseases for oncology. 2nd ed. Geneva: World Health Organization; 1990. Percy C, Van Holten V, Muir C, editors. International classification of diseases for oncology. 2nd ed. Geneva: World Health Organization; 1990.
19.
go back to reference Travis WD, Brambilla E, Muller-Hermelink HK, Harris CC, editors. World Health Organization classification of tumours. pathology and genetics of tumours of the lung, pleura, thymus and heart. Lyon: IARC Press; 2004. Travis WD, Brambilla E, Muller-Hermelink HK, Harris CC, editors. World Health Organization classification of tumours. pathology and genetics of tumours of the lung, pleura, thymus and heart. Lyon: IARC Press; 2004.
20.
go back to reference Bray FI, Weiderpass E. Lung cancer mortality trends in 36 European countries: secular trends and birth cohort patterns by sex and region 1970–2007. Int J Cancer. 2010;126:1454–66.PubMed Bray FI, Weiderpass E. Lung cancer mortality trends in 36 European countries: secular trends and birth cohort patterns by sex and region 1970–2007. Int J Cancer. 2010;126:1454–66.PubMed
22.
go back to reference Bosetti C, Malvezzi M, Rosso T, Bertuccio P, Gallus S, Chatenoud L, et al. Lung cancer mortality in European women: trends and predictions. Lung Cancer. 2012;78:171–8.CrossRefPubMed Bosetti C, Malvezzi M, Rosso T, Bertuccio P, Gallus S, Chatenoud L, et al. Lung cancer mortality in European women: trends and predictions. Lung Cancer. 2012;78:171–8.CrossRefPubMed
23.
go back to reference Levi F, Bosetti C, Fernandez E, Hill C, Lucchini F, Negri E, et al. Trends in lung cancer among young European women: the rising epidemic in France and Spain. Int J Cancer. 2007;121:462–5.CrossRefPubMed Levi F, Bosetti C, Fernandez E, Hill C, Lucchini F, Negri E, et al. Trends in lung cancer among young European women: the rising epidemic in France and Spain. Int J Cancer. 2007;121:462–5.CrossRefPubMed
24.
go back to reference La Vecchia C, Bosetti C, Lucchini F, Bertuccio P, Negri E, Boyle P, et al. Cancer mortality in Europe, 2000–2004, and an overview of trends since 1975. Ann Oncol. 2010;21:1323–60.CrossRefPubMed La Vecchia C, Bosetti C, Lucchini F, Bertuccio P, Negri E, Boyle P, et al. Cancer mortality in Europe, 2000–2004, and an overview of trends since 1975. Ann Oncol. 2010;21:1323–60.CrossRefPubMed
25.
go back to reference Lortet-Tieulent J, Soerjomataram I, Ferlay J, Rutherford M, Weiderpass E, Bray F. International trends in lung cancer incidence by histological subtype: adenocarcinoma stabilizing in men but still increasing in women. Lung Cancer. 2014;84(1):13–22. doi:10.1016/j.lungcan.2014.01.009.CrossRefPubMed Lortet-Tieulent J, Soerjomataram I, Ferlay J, Rutherford M, Weiderpass E, Bray F. International trends in lung cancer incidence by histological subtype: adenocarcinoma stabilizing in men but still increasing in women. Lung Cancer. 2014;84(1):13–22. doi:10.​1016/​j.​lungcan.​2014.​01.​009.CrossRefPubMed
26.
go back to reference Jemal A, Travis WD, Tarone RE, Travis L, Devesa SS. Lung cancer rates convergence in young men and women in the United States: analysis by birth cohortand histologic type. Int J Cancer. 2003;105:101–7.CrossRefPubMed Jemal A, Travis WD, Tarone RE, Travis L, Devesa SS. Lung cancer rates convergence in young men and women in the United States: analysis by birth cohortand histologic type. Int J Cancer. 2003;105:101–7.CrossRefPubMed
27.
go back to reference Everatt R, Kuzmickiene I, Senulis A. Cigarette smoking and trends in lung cancer incidence in Lithuania: an analysis by histological type. Medicina (Kaunas). 2011;47:222–9. Everatt R, Kuzmickiene I, Senulis A. Cigarette smoking and trends in lung cancer incidence in Lithuania: an analysis by histological type. Medicina (Kaunas). 2011;47:222–9.
28.
go back to reference Patel JD, Bach PB, Kris MG. Lung cancer in US women: a contemporary epidemic. JAMA. 2004;291(14):1763–8.CrossRefPubMed Patel JD, Bach PB, Kris MG. Lung cancer in US women: a contemporary epidemic. JAMA. 2004;291(14):1763–8.CrossRefPubMed
29.
go back to reference Thun MJ, Henley SJ, Burns D, Jemal A, Shanks TG, Calle EE. Lung cancer death rate in lifelong nonsmokers. J Natl Cancer Inst. 2006;98:691–9.CrossRefPubMed Thun MJ, Henley SJ, Burns D, Jemal A, Shanks TG, Calle EE. Lung cancer death rate in lifelong nonsmokers. J Natl Cancer Inst. 2006;98:691–9.CrossRefPubMed
Metadata
Title
Trends in lung cancer incidence by histologic subtype in the south of Spain, 1985–2012: a population-based study
Authors
I. Linares
E. Molina-Portillo
J. Expósito
J. A. Baeyens
C. Suárez
M. J. Sánchez
Publication date
01-05-2016
Publisher
Springer Milan
Published in
Clinical and Translational Oncology / Issue 5/2016
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/s12094-015-1392-x

Other articles of this Issue 5/2016

Clinical and Translational Oncology 5/2016 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine